on September 23, 2024 // 4:10-5:00pm EST
As the landscape of payment policies for cell and gene therapies evolves, understanding its impact on access has never been more important. Alicia will share her expertise on value-based arrangements, coverage, and access under employer-sponsored plans and discuss the challenges of prior authorization. She’ll also provide the latest insights on the current political landscape and what to expect in the realm of payment policy updates for 2025. Don’t miss this opportunity to gain valuable knowledge from a leading voice in healthcare policy, alongside a dynamic group of expert panelists:
- Alicia Silver, MPP, ADVI Health
- Pam Traxel, American Cancer Society Cancer Action Network
- Benjamin Rome, MD, Brigham and Women’s Hospital
- Brian Miller, MD, Johns Hopkins University School of Medicine
- Moderator: Zachary Brennan, Endpoints News